The Potential Angiotensin-Converting Enzyme Inhibitory Activity of Oleanolic Acid in the Hydroethanolic Extract of Crataegus monogyna Jacq
Authors:
Open Access
- 1 May 2006
- journal article
- research article
- Published by SAGE Publications in Natural Product Communications
- Vol. 1 (5)
Abstract
The hydroethanolic extract of Crataegus monogyna was studied for its chemical constitution and angiotensin-converting enzyme (ACE) inhibitory activity. The extract contained triterpenic acids, flavonoids and coumarins. The ACE inhibitory activity was studied using captropril, as a control drug, and oleanolic acid, as a constituent of the hydroethanolic extract and a member of the triterpenic acid group. The hydroethanolic extract and oleanolic acid showed higher IC50 values (335.00 μg/mL and 3.61 μM, respectively) in comparison to captopril (46.9 nM). However, these results indicate the anti-ACE activity of oleanolic acid and the triterpenic acids, which has not been demonstrated earlier for hawthorn extracts. In previous studies, the ACE inhibitory activity of C. monogyna extracts was always attributed to flavonoids and proanthocyanidins.Keywords
This publication has 29 references indexed in Scilit:
- Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?Nature Clinical Practice Cardiovascular Medicine, 2005
- Evaluation of bioactive saponins and triterpenoidal aglycons for their binding properties on human endothelin ETA and angiotensin AT1 receptorsPhytotherapy Research, 2004
- Tissue Angiotensin-Converting-Enzyme (ACE) Deficiency Leads to a Reduction in Oxidative Stress and in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Quantitative Spectrophotometric Microplate Assay for Angiotensin-converting Enzyme in Cerebrospinal FluidClinical Chemistry, 2003
- Isolation of Angiotensin Converting Enzyme (ACE) Inhibiting Triterpenes fromSchinus mollePlanta Medica, 1997
- A New Method for thein vitroScreening of Inhibitors of Angiotensin-Converting Enzyme (ACE), Using the Chromophore- and Fluorophore-Labelled Substrate, DansyltriglycinePlanta Medica, 1991
- Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum.Chemical and Pharmaceutical Bulletin, 1986
- Herzwirksame Drogen IV*Planta Medica, 1982
- Crataegus, Toxikologie und Pharmakologie*,** Teil I: ToxizitätPlanta Medica, 1981
- Über Inhaltsstoffe von Crataegus oxyacantha L. II. Mitteilung β‐Sitosterin und OleanolsäureHelvetica Chimica Acta, 1952